LENZ Therapeutics (LENZ) Institutional Ownership $23.82 +1.32 (+5.87%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)CurrentInstitutional OwnershipPercentage54.32%Number ofInstitutional Buyers(last 12 months)29TotalInstitutional Inflows(last 12 months)$120.29MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$1.05M Get LENZ Insider Trade Alerts Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LENZ Institutional Buying and Selling by Quarter LENZ Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/17/2025 SG Americas Securities LLC5,458$158K0.0%+20.7%0.020% 1/17/2025 Kelleher Financial Advisors17,023$491K0.2%-18.1%0.062% 1/10/2025 Harbor Capital Advisors Inc.43,989$1.27M0.1%N/A0.160% 11/19/2024Barclays PLC16,463$391K0.0%+273.1%0.060% 11/16/2024Geode Capital Management LLC338,024$8.03M0.0%-6.1%1.229% 11/15/2024Barclays PLC16,463$391K0.0%+273.1%0.060% 11/15/2024Jane Street Group LLC12,027$286K0.0%N/A0.044% 11/15/2024Wellington Management Group LLP24,621$585K0.0%N/A0.090% 11/15/2024State Street Corp289,154$6.87M0.0%+18.7%1.051% 11/15/2024Parkman Healthcare Partners LLC139,357$3.31M0.4%N/A0.507% Get the Latest News and Ratings for LENZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LENZ Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024BBR Partners LLC40,000$950K0.1%+100.0%0.145% 11/14/2024MetLife Investment Management LLC7,672$182K0.0%N/A0.028% 11/13/2024BNP Paribas Financial Markets2,648$63K0.0%-83.9%0.010% 11/13/2024The Manufacturers Life Insurance Company31,309$743K0.0%N/A0.114% 11/12/2024Charles Schwab Investment Management Inc.123,371$2.93M0.0%+197.5%0.449% 11/5/2024BML Capital Management LLC60,000$1.42M0.8%-6.1%0.218% 11/5/2024GSA Capital Partners LLP10,357$246K0.0%N/A0.038% 10/3/2024 SG Americas Securities LLC4,523$107K0.0%N/A0.124% 8/15/2024Deerfield Management Company L.P. Series C17,353$300K0.0%N/A0.476% 8/14/2024Squarepoint Ops LLC10,477$181K0.0%N/A0.287% 8/14/2024Marshall Wace LLP22,554$390K0.0%N/A0.618% 8/9/2024Renaissance Technologies LLC60,166$1.04M0.0%+28.4%1.649% 8/9/2024Dimensional Fund Advisors LP37,190$644K0.0%+58.0%1.019% 8/5/2024BBR Partners LLC20,000$346K0.0%N/A0.548% 8/1/2024Rhumbline Advisers16,812$291K0.0%+265.6%0.461% 7/26/2024Bank of New York Mellon Corp39,737$687K0.0%+255.4%1.089% 7/16/2024 Wealth Enhancement Advisory Services LLC83,103$1.44M0.0%N/A2.277% 5/17/2024RA Capital Management L.P.4,178,823$93.31M1.2%N/A114.488% 5/17/2024Ikarian Capital LLC85,000$1.90M0.2%N/A2.329% 5/16/2024Jacobs Levy Equity Management Inc.37,176$830K0.0%N/A1.019% 5/14/2024American International Group Inc.1,973$44K0.0%N/A0.054% 5/10/2024Vanguard Group Inc.206,952$4.62M0.0%N/A5.670% 5/7/2024 Marquette Asset Management LLC5,865$131K0.0%N/A0.161% 5/2/2024Jennison Associates LLC134,740$3.01M0.0%N/A3.692% 5/1/2024BNP Paribas Financial Markets16,221$362K0.0%N/A0.444% 4/25/2024BML Capital Management LLC63,916$1.43M0.9%N/A1.751% (Data available from 1/1/2016 forward) LENZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LENZ shares? During the previous two years, 31 institutional investors and hedge funds held shares of LENZ Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($93.31M), Geode Capital Management LLC ($8.03M), State Street Corp ($6.87M), Vanguard Group Inc. ($4.62M), Parkman Healthcare Partners LLC ($3.31M), Jennison Associates LLC ($3.01M), and Charles Schwab Investment Management Inc. ($2.93M).Learn more on LENZ's institutional investors. What percentage of LENZ Therapeutics stock is owned by institutional investors? 54.32% of LENZ Therapeutics stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings. Which institutional investors have been buying LENZ Therapeutics stock? Of the 29 institutional investors that purchased LENZ Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.18M), Vanguard Group Inc. ($206.95K), Parkman Healthcare Partners LLC ($139.36K), Jennison Associates LLC ($134.74K), Ikarian Capital LLC ($85K), Wealth Enhancement Advisory Services LLC ($83.10K), and Charles Schwab Investment Management Inc. ($81.90K). How much institutional buying is happening at LENZ Therapeutics? Institutional investors have bought a total of 5,398,269 shares in the last 24 months. This purchase volume represents approximately $120.29M in transactions. Which LENZ Therapeutics major shareholders have been selling company stock? The following institutional investors have sold LENZ Therapeutics stock in the last 24 months: Geode Capital Management LLC ($22.10K), BNP Paribas Financial Markets ($13.82K), BML Capital Management LLC ($3.92K), and Kelleher Financial Advisors ($3.75K). How much institutional selling is happening at LENZ Therapeutics? Institutional investors have sold a total of 43,584 shares in the last 24 months. This volume of shares sold represents approximately $1.05M in transactions. Related Companies ARWR Institutional Ownership MIRM Institutional Ownership HRMY Institutional Ownership CGON Institutional Ownership PTGX Institutional Ownership NAMS Institutional Ownership JANX Institutional Ownership VERA Institutional Ownership IBRX Institutional Ownership CNTA Institutional Ownership This page (NASDAQ:LENZ) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LENZ Stock Alerts